Cristina Martínez-Fernández de la Cámara Selected Research

zaprinast

1/2016	cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants.
10/2014	Infliximab reduces Zaprinast-induced retinal degeneration in cultures of porcine retina.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristina Martínez-Fernández de la Cámara Research Topics

Disease

5	Retinal Degeneration 01/2018 - 06/2013
3	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2014 - 01/2013
2	Inflammation (Inflammations) 10/2014 - 06/2013
2	Retinal Dystrophies 10/2014 - 06/2013
1	Neuroinflammatory Diseases 01/2018
1	Gliosis 01/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2016
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2016
1	Ischemia 01/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Retinal Artery Occlusion 01/2016
1	Glaucoma 01/2016

Drug/Important Bio-Agent (IBA)

3	AntioxidantsIBA 01/2018 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2013
2	Superoxide DismutaseIBA 01/2016 - 01/2013
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2016 - 06/2013
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2016 - 06/2013
2	zaprinastIBA 01/2016 - 10/2014
2	Caspase 3 (Caspase-3)IBA 01/2016 - 10/2014
2	Type 6 Cyclic Nucleotide PhosphodiesterasesIBA 10/2014 - 06/2013
1	Prolyl-Hydroxylase InhibitorsIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Endothelin-1 (Endothelin 1)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2018
1	CaspasesIBA 01/2016
1	Retinaldehyde (Retinal)IBA 01/2016
1	Superoxides (Superoxide)IBA 01/2016
1	CatalaseIBA 01/2016
1	Free RadicalsIBA 01/2016
1	Adalimumab (Humira)FDA Link 07/2015
1	Interleukin-6 (Interleukin 6)IBA 10/2014
1	Infliximab (Remicade)FDA Link 10/2014
1	Oxidants (Oxidizing Agents)IBA 01/2013
1	Cyclic GMPIBA 01/2013
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2013
1	3-nitrotyrosineIBA 01/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2013
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013